Skip to main content
  • Register
  • Help
  • Contact us
  • Log out of your HL account

Genedrive plc (GDR) Ordinary 1.5p Shares

Sell:20.00p Buy:23.00p 0 Change: No change
Market closed Prices as at close on 10 December 2019 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:20.00p
Buy:23.00p
Change: No change
Market closed Prices as at close on 10 December 2019 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:20.00p
Buy:23.00p
Change: No change
Market closed Prices as at close on 10 December 2019 Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Genedrive Plc is a United Kingdom-based holding company engaged in molecular diagnostics business. The Company provides a molecular diagnostics platform for the diagnosis of infectious diseases and for use in patient stratification (genotyping), pathogen detection and other indications. Its geographical segments include the United Kingdom, Europe, the United States of America and Asia. Genedrive is a small polymerase chain reaction (PCR) platform, which enables nucleic acid amplification and detection from various sample types, including plasma, sputum and buccal swabs. Genedrive system includes Genedrive hepatitis C virus (HCV) ID Kit for detection of Hepatitis C, and Genedrive IL28B ID Kit for the detection of Interleukin 28B genotyping status.

Contact details

Address:
48 Grafton Street
MANCHESTER
M13 9XX
United Kingdom
Telephone:
+44 (0161) 9890245
Website:
www.genedriveplc.com/

Important dates

Future events
There are no future events available.
Past events
AGM 27 November 2019 27/11/19
Final results 03 October 2019 03/10/19
Trading Announcement 09 July 2019 09/07/19
Interim results 28 March 2019 28/03/19
Trading Announcement 15 January 2019 15/01/19
AGM 31 December 2018 31/12/18

General stock information

EPIC:
GDR
ISIN:
GB00B1VKB244
Market cap:
£7.31 million
Shares in issue:
34.00 million
Sector:
Pharmaceuticals & Biotechnology
Exchange:
London Stock Exchange
Currency:
Sterling pence
Indices:
n/a

Key personnel

  • David Budd
    Chief Executive Officer, Director
  • Matthew Fowler
    Chief Financial Officer, Director
  • H. John Rylands
    Financial Director, Company Secretary, Executive Director
  • Catherine Booth
    Managing Director - Contract Research Services, Executive Director

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by NBTrader.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.